✦ LIBER ✦

32-W: Acute humoral rejection (AHR) after combined liver and kidney transplant (LKTx)

✍ Scribed by Susan L. Saidman; Dean Sylvaria; Amy Powers; Isaac E. Stillman; Martha Pavlakis; Douglas W. Hanto

Book ID: 116532615
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 33 KB
Volume: 70
Category: Article
ISSN: 0198-8859
DOI: 10.1016/j.humimm.2009.09.328

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute Humoral Rejection in an ABO Compat

Acute Humoral Rejection in an ABO Compatible Combined Liver–Kidney Transplant—The Kidney Is Not Always Protected

✍ T. W. Reichman; S. R. Marino; J. Milner; R. C. Harland; A. Cochrane; J. M. Milli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Humoral and cellular rejection after com

Humoral and cellular rejection after combined liver–kidney transplantation in low immunologic risk recipients

✍ Karine Hadaya; Sylvie Ferrari-Lacraz; Emiliano Giostra; Pietro Majno; Solange Mo 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 492 KB

Alloantibody Levels and Acute Humoral Re

Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation

✍ J. M. Burns; L. D. Cornell; D. K. Perry; H. S. Pollinger; J. M. Gloor; W. K. Kre 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

Diagnosis and treatment of acute humoral

Diagnosis and treatment of acute humoral rejection after kidney transplantation: preliminary experience

✍ M Crespo; M Lozano; M Sole; J Mila; N Esforzado; J Martorell; F Oppenheimer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Isolated Acute Cellular Rejection of the

Isolated Acute Cellular Rejection of the Liver After Simultaneous Liver and Kidney Transplantation: A Case Report

✍ Y.W. Nah; C.W. Nam; J.H. Suh; H.J. Cha; G.Y. Kim; S.J. Park; Y. Oh; H.R. Cho 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 525 KB

Outcomes of acute rejection after interf

Outcomes of acute rejection after interferon therapy in liver transplant recipients

✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir